Amid increasing reports of sexual assaults among college students, the Integrated Innovation Institute at Carnegie Mellon University is applying its distinctive innovation approach to accelerate marketable solutions to combat acquaintance/date rape. Two novel product prototypes, targeted to the college population and designed by graduate-student teams, employ mobile technology to galvanize bystander intervention and engender shared community responsibility.
To view the multimedia assets associated with this release, please click: http://www.multivu.com/players/English/7281051-carnegie-mellon-integrated-innovation-institute-students-innovate-against-rape/
Global biotherapeutics leader CSL Behring today announced that results were published in the New England Journal of Medicine (NEJM) from the COMPACT study, a pivotal Phase III study evaluating the safety and efficacy of CSL830 (a novel, investigational, self-administered, subcutaneous C1-Esterase Inhibitor [C1-INH] Human replacement therapy) for the prevention of HAE attacks. The study met its primary efficacy endpoint, significantly reducing the time-normalized number of HAE attacks. In addition, the study met its secondary endpoints, including the responder rate (patients who had at least a 50% reduction in their attack rate) and the number of rescue medication uses. If approved by the FDA, CSL830 would be the first and only subcutaneous preventative therapy for HAE.
To view the multimedia release go to:
https://www.multivu.com/players/English/8056151-csl-behring-subcutaneous-c1-esterase-inhibitor-hae-patients/
Antoine’s – an icon and a standard bearer for traditional French Creole culinary traditions in America – will commemorate its 175th anniversary in 2015 with a year of special events, menus and celebrations inside the walls of its fabled French Quarter dining rooms, as well as in other markets around the country. The legendary New Orleans restaurant is the oldest continuously operating restaurant in America, the birthplace of Oysters Rockefeller, and remains owned by the same family that started it nearly two centuries ago. “Dinner at Antoine’s” is such an experience that those three words fittingly served as the title to a famous novel, and the restaurant’s namesake is considered “the father of Creole cooking.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7412051-new-orleans-restaurant-antoines/
Solta Medical's novel addition to its aesthetic device solutions, the Clear + Brilliant pélo™ laser, offers personalized results with groundbreaking laser hair removal [LHR] technology to make it fast and simple with minimal pain for anyone to get rid of unwanted hair.
The Clear + Brilliant pélo™ laser provides a highly effective treatment in a short amount of time due to its innovative linear scanning technology and the largest treatment window in the market. A full back takes only 8-12 minutes, and full legs take about 36 minutes. After 5-6 treatments, patients can see the results they want, and still have money in their pocket for the long run.
Each treatment can be customized depending on the individual's needs, and patient comfort is enhanced by minimizing pain on contact through a sapphire glass handpiece that quickly chills to 0°C. So patients and physicians can rest easy that their individual needs are met.
To view the multimedia release go to:
http://www.multivu.com/players/English/7621831-clear-brilliant-pelo-laser-hair-removal/
Award winning Director is going to direct three renowned stars of Hollywood. These frames do not need any introduction. This is a very rare combination and definitely be a block buster.
Adolescents and young adults with a severe inherited immunodeficiency disorder improved following treatment with novel gene therapy developed at St. Jude Children’s Research Hospital and at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The results of this study appear today in the journal Science Translational Medicine.
The study involved five males with X-linked severe combined immunodeficiency disease (SCID-X1), also known as “Bubble Boy” disease, who were all treated at NIAID. This inherited disorder involves a mutation in the IL2RG gene that affects males and occurs in 1 of every 50,000 to 100,000 live births, leaving them with little to no immune protection.
To view the multimedia release go to:
http://www.multivu.com/players/English/7808651-st-jude-gene-therapy-results/
New release on Amazon, Chased into his Destiny, new Best Seller, Best Selling African Novel, African Best Seller Series, new African Author, best seller
